A carregar...
Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma
Background: Immune-checkpoint inhibitors (ICIs) are novel promising agents for the treatment of malignant tumors. However, critical endocrine immune-related adverse events (irAEs) by ICIs often occur. Case report: A 63-year-old woman with advanced malignant melanoma had received anti-PD-1 antibody (...
Na minha lista:
| Publicado no: | In Vivo |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
International Institute of Anticancer Research
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905204/ https://ncbi.nlm.nih.gov/pubmed/29475919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11244 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|